Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14632194rdf:typepubmed:Citationlld:pubmed
pubmed-article:14632194lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:14632194lifeskim:mentionsumls-concept:C0042900lld:lifeskim
pubmed-article:14632194lifeskim:mentionsumls-concept:C0004358lld:lifeskim
pubmed-article:14632194lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:14632194lifeskim:mentionsumls-concept:C1883221lld:lifeskim
pubmed-article:14632194lifeskim:mentionsumls-concept:C0439064lld:lifeskim
pubmed-article:14632194lifeskim:mentionsumls-concept:C0294776lld:lifeskim
pubmed-article:14632194lifeskim:mentionsumls-concept:C1883204lld:lifeskim
pubmed-article:14632194lifeskim:mentionsumls-concept:C1880389lld:lifeskim
pubmed-article:14632194pubmed:issue4lld:pubmed
pubmed-article:14632194pubmed:dateCreated2003-11-24lld:pubmed
pubmed-article:14632194pubmed:abstractTextPreviously, we reported the identification of autoantibodies against the melanin-concentrating hormone receptor 1 in patients with vitiligo. In this study, the B cell epitopes on melanin-concentrating hormone receptor 1 that are recognized by these autoantibodies have been identified. Deletion derivatives of melanin-concentrating hormone receptor 1 complementary DNA were constructed and then translated in vitro with the concomitant incorporation of [35S]-methionine into the protein products. The [35S]-labeled melanin-concentrating hormone receptor 1 derivatives were subsequently used in radio-binding assays to investigate the reactivity of sera from nine vitiligo patients that were known to contain antibodies to the receptor. Analysis of the results obtained in the radio-binding assays suggested the existence of multiple antibody binding sites on melanin-concentrating hormone receptor 1, including regions between amino acids 1 to 138 and 139 to 298. Several patients exhibited autoantibodies to more than one melanin-concentrating hormone receptor 1 epitope indicating a heterogeneous humoral response to the receptor. Computer prediction of the potential B cell epitopes on melanin-concentrating hormone receptor 1 revealed that the epitope domains identified overlapped, at least in part, with regions predicted to be highly antigenic.lld:pubmed
pubmed-article:14632194pubmed:languageenglld:pubmed
pubmed-article:14632194pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14632194pubmed:citationSubsetIMlld:pubmed
pubmed-article:14632194pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14632194pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14632194pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14632194pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14632194pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14632194pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14632194pubmed:statusMEDLINElld:pubmed
pubmed-article:14632194pubmed:monthOctlld:pubmed
pubmed-article:14632194pubmed:issn0022-202Xlld:pubmed
pubmed-article:14632194pubmed:authorpubmed-author:GawkrodgerDav...lld:pubmed
pubmed-article:14632194pubmed:authorpubmed-author:KempE HelenEHlld:pubmed
pubmed-article:14632194pubmed:authorpubmed-author:WatermanEliza...lld:pubmed
pubmed-article:14632194pubmed:authorpubmed-author:GottumukkalaR...lld:pubmed
pubmed-article:14632194pubmed:authorpubmed-author:WeetmanAnthon...lld:pubmed
pubmed-article:14632194pubmed:authorpubmed-author:WatsonPhilip...lld:pubmed
pubmed-article:14632194pubmed:authorpubmed-author:HerdLaura MLMlld:pubmed
pubmed-article:14632194pubmed:issnTypePrintlld:pubmed
pubmed-article:14632194pubmed:volume121lld:pubmed
pubmed-article:14632194pubmed:ownerNLMlld:pubmed
pubmed-article:14632194pubmed:authorsCompleteYlld:pubmed
pubmed-article:14632194pubmed:pagination765-70lld:pubmed
pubmed-article:14632194pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:14632194pubmed:meshHeadingpubmed-meshheading:14632194...lld:pubmed
pubmed-article:14632194pubmed:meshHeadingpubmed-meshheading:14632194...lld:pubmed
pubmed-article:14632194pubmed:meshHeadingpubmed-meshheading:14632194...lld:pubmed
pubmed-article:14632194pubmed:meshHeadingpubmed-meshheading:14632194...lld:pubmed
pubmed-article:14632194pubmed:meshHeadingpubmed-meshheading:14632194...lld:pubmed
pubmed-article:14632194pubmed:meshHeadingpubmed-meshheading:14632194...lld:pubmed
pubmed-article:14632194pubmed:meshHeadingpubmed-meshheading:14632194...lld:pubmed
pubmed-article:14632194pubmed:meshHeadingpubmed-meshheading:14632194...lld:pubmed
pubmed-article:14632194pubmed:meshHeadingpubmed-meshheading:14632194...lld:pubmed
pubmed-article:14632194pubmed:meshHeadingpubmed-meshheading:14632194...lld:pubmed
pubmed-article:14632194pubmed:meshHeadingpubmed-meshheading:14632194...lld:pubmed
pubmed-article:14632194pubmed:meshHeadingpubmed-meshheading:14632194...lld:pubmed
pubmed-article:14632194pubmed:meshHeadingpubmed-meshheading:14632194...lld:pubmed
pubmed-article:14632194pubmed:meshHeadingpubmed-meshheading:14632194...lld:pubmed
pubmed-article:14632194pubmed:meshHeadingpubmed-meshheading:14632194...lld:pubmed
pubmed-article:14632194pubmed:year2003lld:pubmed
pubmed-article:14632194pubmed:articleTitleAutoantibodies in vitiligo patients recognize multiple domains of the melanin-concentrating hormone receptor.lld:pubmed
pubmed-article:14632194pubmed:affiliationDivision of Clinical Sciences (North), University of Sheffield, Sheffield, UK.lld:pubmed
pubmed-article:14632194pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14632194pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:2847entrezgene:pubmedpubmed-article:14632194lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:14632194lld:entrezgene